Artemis Investment Management LLP Acquires Shares of 88,295 Johnson & Johnson (JNJ)

Artemis Investment Management LLP acquired a new position in Johnson & Johnson (NYSE:JNJ) in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund acquired 88,295 shares of the company’s stock, valued at approximately $11,478,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Vanguard Group Inc. grew its holdings in Johnson & Johnson by 1.5% during the second quarter. Vanguard Group Inc. now owns 200,450,985 shares of the company’s stock valued at $26,517,661,000 after purchasing an additional 3,023,110 shares during the period. BlackRock Inc. grew its holdings in Johnson & Johnson by 2.6% during the second quarter. BlackRock Inc. now owns 174,073,764 shares of the company’s stock valued at $23,028,219,000 after purchasing an additional 4,332,612 shares during the period. FMR LLC grew its holdings in Johnson & Johnson by 5.9% during the second quarter. FMR LLC now owns 27,237,648 shares of the company’s stock valued at $3,603,268,000 after purchasing an additional 1,509,745 shares during the period. Capital World Investors grew its holdings in Johnson & Johnson by 4.1% during the second quarter. Capital World Investors now owns 26,510,007 shares of the company’s stock valued at $3,507,009,000 after purchasing an additional 1,050,000 shares during the period. Finally, Ameriprise Financial Inc. grew its holdings in Johnson & Johnson by 4.5% during the second quarter. Ameriprise Financial Inc. now owns 17,860,047 shares of the company’s stock valued at $2,363,788,000 after purchasing an additional 771,039 shares during the period. 65.71% of the stock is owned by institutional investors.

Shares of Johnson & Johnson (JNJ) opened at $147.36 on Friday. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.32 and a quick ratio of 1.02. The company has a market capitalization of $395,890.00, a PE ratio of 25.58, a P/E/G ratio of 2.75 and a beta of 0.80. Johnson & Johnson has a 52-week low of $110.76 and a 52-week high of $148.32.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 13th. Investors of record on Tuesday, February 27th will be given a $0.84 dividend. The ex-dividend date is Monday, February 26th. This represents a $3.36 dividend on an annualized basis and a dividend yield of 2.28%. Johnson & Johnson’s dividend payout ratio is currently 58.33%.

Several equities analysts have recently commented on the company. Wells Fargo & Co restated an “outperform” rating and issued a $160.00 price objective (up from $155.00) on shares of Johnson & Johnson in a research report on Friday, January 12th. Vetr upgraded Johnson & Johnson from a “hold” rating to a “buy” rating and set a $150.89 price objective on the stock in a research report on Thursday, January 11th. Royal Bank of Canada restated a “buy” rating on shares of Johnson & Johnson in a research report on Tuesday, January 9th. Citigroup boosted their price objective on Johnson & Johnson from $140.00 to $149.00 and gave the company a “buy” rating in a research report on Monday, October 23rd. Finally, Zacks Investment Research downgraded Johnson & Johnson from a “buy” rating to a “hold” rating in a research report on Tuesday, December 12th. Four equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and eleven have given a buy rating to the stock. Johnson & Johnson currently has an average rating of “Hold” and an average price target of $145.94.

ILLEGAL ACTIVITY NOTICE: This news story was first posted by Ticker Report and is the sole property of of Ticker Report. If you are viewing this news story on another website, it was copied illegally and reposted in violation of US & international trademark and copyright law. The correct version of this news story can be accessed at https://www.tickerreport.com/banking-finance/3148393/artemis-investment-management-llp-acquires-shares-of-88295-johnson-johnson-jnj.html.

Johnson & Johnson Profile

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being.

Want to see what other hedge funds are holding JNJ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Johnson & Johnson (NYSE:JNJ).

Institutional Ownership by Quarter for Johnson & Johnson (NYSE:JNJ)

Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


© 2006-2018 Ticker Report. Google+.